Author

Lin Cao

The University of Texas at San Antonio Health Science CenterORCID 0000-0002-4773-8219Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Daohong ZhouiD· 1 shared Guangrong ZhengiD· 1 shared Javed Miyan· 1 shared Jose TrevinoiD· 1 shared Lei ZhengiD· 1 shared Peiyi ZhangiD· 1 shared Sajid Khan· 1 shared Vignesh VudathaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Daohong ZhouORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 5, 2026

The combination of BCL-xL PROTAC and mTOR inhibitor sensitizes pancreatic ductal adenocarcinoma to KRASG12D inhibitor treatment by enhancing apoptosis induction

Javed Miyan, Vignesh Vudatha, Lin Cao…·Sajid Khan

This paper shows that combining BCL-xL PROTAC and mTOR inhibitor with KRASG12D inhibitor enhances apoptosis and overcomes resistance in PDAC.

DOI 10.64898/2026.01.05.697773

humanexperimental assay

𝕏 PostBluesky